Diabetes Mellitus, Type 2 Clinical Trial
— REALOfficial title:
Diabetes Self-Management Lifestyle Intervention for Urban Minority Young Adults
| Verified date | October 2019 |
| Source | University of Southern California |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This three-year award will pilot-test an innovative intervention, Resilient, Empowered,
Active Living with Diabetes (REAL), targeting underserved minority young adults with
poorly-controlled diabetes. The individually tailored, community-based intervention merges
findings of an in-depth needs assessment, principles of an evidence-based occupational
therapy intervention (Lifestyle Redesign®) and evidence-based diabetes self-management
strategies. A proof-of-concept study demonstrated that REAL is feasible to implement,
acceptable to young adults with type 1 diabetes and type 2 diabetes, and has potential to
produce positive changes in diabetes self-care and glycemic control. The study will randomize
80 young adults with diabetes to receive either the six-month REAL intervention or an
attention control condition. Blinded data collectors will assess glycemic control, diabetes
self-care behaviors and quality of life outcomes, as well as potential intervention
mediators, before and after the six-month intervention. It is anticipated that findings from
this pilot study will be used to inform a large-scale randomized controlled trial of the REAL
intervention.
The study's specific aims and hypotheses are as follows:
Aim 1. Determine the intervention's efficacy for the primary outcomes: glycemic control and
diabetes self-care.
Hypothesis: At 6 months (immediately following the intervention), intervention group
participants will demonstrate improvements in A1C and diabetes self-care as compared to
control group participants.
Aim 2. Conduct exploratory analyses of the intervention's impact on secondary outcomes and
potential mediating mechanisms (to inform power estimates for a large-scale RCT).
Hypothesis 1: At 6 months, intervention group participants will demonstrate improvements in
secondary outcomes: diabetes-related stress and quality of life, depression, and life
satisfaction as compared to control group participants.
Hypothesis 2: At 6 months, intervention group participants will demonstrate improvements in
potential mediators of the intervention: habit strength, problem solving, activity
participation, self-efficacy and diabetes knowledge as compared to baseline.
Aim 3. Conduct a process evaluation utilizing mixed methods to evaluate and refine
intervention delivery (e.g. treatment fidelity, patient satisfaction) and study procedures
(e.g. recruitment, retention, testing protocol).
| Status | Completed |
| Enrollment | 81 |
| Est. completion date | July 2017 |
| Est. primary completion date | June 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 30 Years |
| Eligibility |
Inclusion Criteria: - Diagnosed with type 1 or type 2 diabetes mellitus for a minimum of 12 months - Most recent A1C =8.0% - Fluent in English or Spanish - Reachable by telephone or text message - Willing to participate in study activities - Reside in Los Angeles County with no plans to relocate Exclusion Criteria: - Pregnant or planning to become pregnant - Cognitive impairment or severe disability limiting life expectancy - Participated in lifestyle intervention targeting diabetes within past 12 months - Participated in formative research related to intervention development. |
| Country | Name | City | State |
|---|---|---|---|
| United States | USC | Los Angeles | California |
| Lead Sponsor | Collaborator |
|---|---|
| University of Southern California | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
Carandang KM, Pyatak EA. Feasibility of a Manualized Occupation-Based Diabetes Management Intervention. Am J Occup Ther. 2018 Mar/Apr;72(2):7202345040p1-7202345040p6. doi: 10.5014/ajot.2018.021790. — View Citation
Pyatak EA, Carandang K, Davis S. Developing a Manualized Occupational Therapy Diabetes Management Intervention: Resilient, Empowered, Active Living With Diabetes. OTJR (Thorofare N J). 2015 Jul;35(3):187-94. — View Citation
Pyatak EA, Carandang K, Vigen C, Blanchard J, Sequeira PA, Wood JR, Spruijt-Metz D, Whittemore R, Peters AL. Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) study: Methodology and baseline characteristics of a randomized controlled trial evaluating an occupation-based diabetes management intervention for young adults. Contemp Clin Trials. 2017 Mar;54:8-17. doi: 10.1016/j.cct.2016.12.025. Epub 2017 Jan 5. — View Citation
Pyatak EA, Carandang K, Vigen CLP, Blanchard J, Diaz J, Concha-Chavez A, Sequeira PA, Wood JR, Whittemore R, Spruijt-Metz D, Peters AL. Occupational Therapy Intervention Improves Glycemic Control and Quality of Life Among Young Adults With Diabetes: the R — View Citation
Pyatak EA, Florindez D, Peters AL, Weigensberg MJ. "We are all gonna get diabetic these days": the impact of a living legacy of type 2 diabetes on Hispanic young adults' diabetes care. Diabetes Educ. 2014 Sep-Oct;40(5):648-58. doi: 10.1177/0145721714535994. Epub 2014 May 27. — View Citation
Pyatak EA, Florindez D, Weigensberg MJ. Adherence decision making in the everyday lives of emerging adults with type 1 diabetes. Patient Prefer Adherence. 2013 Jul 29;7:709-18. doi: 10.2147/PPA.S47577. Print 2013. — View Citation
Pyatak EA, Sequeira PA, Whittemore R, Vigen CP, Peters AL, Weigensberg MJ. Challenges contributing to disrupted transition from paediatric to adult diabetes care in young adults with type 1 diabetes. Diabet Med. 2014 Dec;31(12):1615-24. doi: 10.1111/dme.12485. Epub 2014 May 26. — View Citation
Vigen CLP, Carandang K, Blanchard J, Sequeira PA, Wood JR, Spruijt-Metz D, Whittemore R, Peters AL, Pyatak EA. Psychosocial and Behavioral Correlates of A1C and Quality of Life Among Young Adults With Diabetes. Diabetes Educ. 2018 Dec;44(6):489-500. doi: 10.1177/0145721718804170. Epub 2018 Oct 8. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Glycated hemoglobin (HbA1C) | Measure of average blood glucose concentration over approximately the previous 12 weeks. | Baseline & 6 months. | |
| Secondary | Audit of Diabetes-Dependent Quality of Life (ADD-QoL) | 19-item survey measure assessing impact of diabetes on social, physical, and emotional functioning. | Baseline & 6 months. | |
| Secondary | Problem Areas in Diabetes (PAID) Scale - Short Form | 5-item survey measure assessing diabetes-related distress and emotional problems. | Baseline & 6 months. | |
| Secondary | Patient Health Questionnaire-8 (PHQ-8) | 8-item survey measure assessing severity of depressive symptoms (identical to PHQ-9 while omitting self-harm item). | Baseline & 6 months | |
| Secondary | Satisfaction With Life Scale (SWLS) | 5-item survey measure assessing global life satisfaction and subjective well-being. | Baseline & 6 months. | |
| Secondary | Summary of Diabetes Self-Care Activities (SDSCA) | 14 items assessing diet, physical activity, medication adherence and other self-care behaviors relevant to diabetes. | Baseline & 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |